Related Experiment Video
Updated: Aug 15, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
[Azithromycin in the prevention of Mediterranean spotted fever]
B Dzelalija1, M Morović, T Avsic-Zupanc
1Sluzba za lijecenje zaraznih bolesti, Opća bolnica Zadar.
Abstract:
Antibodies to Rickettsia conorii were detected by the indirect immunofluorescence (IFA) assay in 64 (51.6%) out of 124 examinees living in North Dalmatia (Croatia) who had a history of recent tick bites during 1994 and 1995. Positive titers of IFA antibodies to R. conorii were detected in 12 (31.5%) out of 38 examinees with carried out prophylaxis by azithromycin. The usual clinical signs of Mediterranean spotted fever were registered in 22 (25.6%) and asymptomatic infection in 30 (34.8%) out of 86 examinees without prophylaxis. Clinical signs of the disease were not registered in examinees with prophylaxis.
Insights
Antibodies to Rickettsia conorii were found in over half of tick-bite patients in Croatia. Prophylaxis with azithromycin may prevent Mediterranean spotted fever symptoms.
Area of Science:
- Infectious Diseases
- Immunology
- Epidemiology
Context:
- Mediterranean spotted fever is a tick-borne illness caused by Rickettsia conorii.
- North Dalmatia, Croatia, is an endemic area for tick-borne diseases.
- Tick bite history and serological evidence are key diagnostic indicators.
Purpose:
- To investigate the prevalence of Rickettsia conorii antibodies in individuals with a history of tick bites.
- To assess the effectiveness of azithromycin prophylaxis in preventing Mediterranean spotted fever.
- To correlate serological findings with clinical manifestations of the disease.
Summary:
- Antibodies to Rickettsia conorii were detected in 51.6% of 124 individuals in North Dalmatia, Croatia, with a history of tick bites.
- Among those who received azithromycin prophylaxis, 31.5% showed positive Rickettsia conorii antibody titers, but none exhibited clinical signs of Mediterranean spotted fever.
- In individuals without prophylaxis, 25.6% presented with clinical Mediterranean spotted fever, while 34.8% had asymptomatic infections.
Impact:
- This study highlights the significant seroprevalence of Rickettsia conorii in a region with endemic tick-borne diseases.
- Findings suggest that azithromycin prophylaxis may be effective in preventing the clinical manifestation of Mediterranean spotted fever.
- The research underscores the importance of serological monitoring and prophylactic measures in tick-exposed populations.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Endocarditis III: Medical Management
Rocky Mountain Spotted Fever
Trichomoniasis
Anthelminthic Agents
Antiprotozoal Agents

